EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy

Haibo Wang

Eye and Brain · 2016-05 · 81

DOI: 10.2147/eb.s94449 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Eye and Brain, 2016-05. Verfasst von Haibo Wang. Beteiligte Einrichtung: Department of Ophthalmology, John A Moran Eye Center, The University of Utah, Salt Lake City, UT, USA. Die Arbeit wurde bisher 31-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

intravitreal neovascularizationoxygen-induced retinopathy modelphysiological retinal vascular developmentretinopathy of prematurityvascular endothelial growth factor

Autor:innen und Institutionen

  • Department of Ophthalmology, John A Moran Eye Center, The University of Utah, Salt Lake City, UT, USA.

Zitieren

APA

Wang, H. (2016). Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye and Brain, 81. https://doi.org/10.2147/eb.s94449

Vancouver

Wang H. Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye and Brain. 2016:81. doi:10.2147/eb.s94449

BibTeX
@article{Wang2016,
  author = {Wang, Haibo},
  title = {Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy},
  journal = {Eye and Brain},
  year = {2016},
  pages = {81},
  doi = {10.2147/eb.s94449}
}
Kostenlos starten →